Navigation Links
David Mack Joins Ameritox as Vice President for Human Resources
Date:4/22/2009

BALTIMORE, April 22 /PRNewswire/ -- Ameritox, the U.S. leader in pain prescription monitoring, is pleased to announce that David Mack has joined the company as vice president of human resources. Mack will oversee all of the company's human resource functions, including recruiting, employee relations, benefits, training and organizational development.

"David has tremendous experience helping companies grow and develop into sophisticated, highly successful organizations," said Ancelmo E. Lopes, CEO of Ameritox. "He will help us continue to focus on innovation, outstanding customer service, and providing physicians and other prescribers with important tools to help them better monitor their patients' pain medication."

Mr. Mack brings a wealth of experience in all aspects of human resources. He began his career as an Army officer, working in personnel management for four years. He then joined GE, working in its Aircraft and Motors and Industrial divisions. There, he was responsible for succession planning activities, talent development, recruiting, organizational design and development, and compensation plans for up to 20,000 employees.

After GE, David became vice president for human resources for ARAMARK, where he developed and implemented the overall human resource strategy for two business units and 3,100 employees. He also has served as senior vice president of human resources for Atria Senior Living Group, and as a senior consultant for Positive Management Leadership, a firm that provides crisis management and leadership training to FORTUNE 500 companies.

David Mack earned a bachelor's degree in psychology and history from the University of Cincinnati, and a master's of science degree in Human Resource Management from Chapman University. He will be based at Ameritox headquarters in Baltimore.

About Ameritox

Ameritox is the nation's leader in pain prescription monitoring, processing thousands of specimens every day. Only Ameritox offers the Rx Guardian(SM) Report, the most thorough and personalized lab report available and the only report that uses a patented methodology to help physicians assess whether patients are taking their pain medication consistent with the dosage prescribed by their physicians. By comparing normalized values to expected prescription-specific ranges, Rx Guardian assists pain practitioners in protecting their patients by providing information to help them assess compliance based on prescription regimens. Rx Guardian also provides peace of mind to physicians and protection to their practices by providing data to help ensure that patients are taking pain medications as prescribed. Ameritox headquarters are located in Baltimore, MD, and its laboratory facilities are in Midland, TX. For additional information, please contact us by phone at 866-926-9264, by e-mail at information.request@ameritox.com, or visit http://www.ameritox.com.

AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.

                                     Contact:   Jennifer Paganelli
                                                Edelman
                                                212-642-7774
                                                jennifer.paganelli@edelman.com


'/>"/>
SOURCE Ameritox
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. David Kaye Launches a New Facilities Services Company to Assist the Growing Biotechnology Business in Maryland
2. JAZD.net Adds David Southwick as SVP of Sales and Service
3. Former Head of Office of Lilly CME, Steve Davidson, RPh, Named Medical Education Specialist at CME Enterprise
4. AstraZenecas David Brennan Elected PhRMA Board Chairman
5. Dr. Norman E. Rosenthal Joins Paul McCartney and David Lynch at Press Conference for Benefit Concert
6. eHealth Initiative Applauds Appointment of David Blumenthal as New National Coordinator for Health Information Technology
7. Dr. Barry Friedberg comments on David vs. Goliath: Whos Really in the Pursuit of Patient Safety & Satisfaction?
8. Media Advisory: Medco CEO David B. Snow Jr. To Address American Enterprise Institute: Health IT: Empowering Precision Medicine
9. David Teuscher, MD, Elected Secretary of Academy Board of Councilors
10. Veteran Rehab Specialist, David Glancy, Joins Fast-Growing Alliance Seating & Mobility in Michigan
11. Paul McCartney to Headline Benefit Concert for David Lynch Foundation at Radio City Music Hall on Saturday, April 4
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , ... May 25, 2016 , ... Casa Velas, an ... properties of precious stones to complement its new wellness suites . The two ... and feature a plethora of special services and insuite amenities, from a custom soap ...
(Date:5/25/2016)... , ... May 25, 2016 , ... America Walks ... Carol Reichbaum, M.S.L., M.S.P.A., of the University of Pittsburgh Graduate School of Public ... will enable Ms. Reichbaum and 24 other advocates from around the country to participate ...
(Date:5/25/2016)... ... 2016 , ... "FCPX LUT Intense allows users to cycle through different high-contrast ... CEO of Pixel Film Studios. , With the FCPX LUT Intense Plugin ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ...
(Date:5/25/2016)... ... May 25, 2016 , ... Consumer access to organic ... June 2016, Kashi®, a maker of whole grain cereals and other plant-based foods, will ... ingredient: hard red winter wheat processed by Hesco/Dakota Organic Products. , The transitional ...
(Date:5/25/2016)... New Jersey (PRWEB) , ... May 25, 2016 , ... ... specialized technology firm will be selling the device branded as Stern’s Real Time ... is geared to bedbugs to the hotel and motel industry, colleges for use in ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... N.J. , May 24, 2016 ... oncology drug development company, today provided an update ... dose escalating clinical trial combining GEN-1, the Company,s ... the treatment of newly-diagnosed patients with advanced ovarian ... interval debulking surgery.  GEN-1 is an IL-12 DNA ...
(Date:5/24/2016)... , May 24, 2016 ... ™ , la première endoprothèse ... cathéters destinés à l,intervention portant sur les ...   OrbusNeich, entreprise mondiale spécialisée ... de changer la vie, a élargi son ...
Breaking Medicine Technology: